Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy

Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy / Boriani, G.; Mei, D. A.; Imberti, J. F.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 25:7(2023), pp. 978-980. [10.1002/ejhf.2891]